Improving detection of genetic variations linked to diseases and cancers
Detecting structural variants in a large population of samples through high-throughput sequencing data
This study is working on new ways to find important genetic changes in people's DNA that could lead to inherited diseases and cancers, using advanced technology to help understand how these changes might affect your health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project ID | NIH-10928181 on NIH RePORTER |
What this research studies
This research focuses on enhancing the detection of structural variants (SVs) in the human genome, which are significant genetic changes that can contribute to inherited diseases and cancers. By utilizing advanced third-generation sequencing technologies, the project aims to develop new computational tools that can analyze large populations of genetic data more effectively. Patients' genetic information will be processed to identify SVs that may increase their risk for specific diseases, providing insights into their genetic predispositions. This approach seeks to bridge existing gaps in genetic research and improve our understanding of complex genetic conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with a family history of hereditary diseases or cancers, as well as those interested in understanding their genetic predisposition.
Not a fit: Patients without a genetic predisposition to hereditary diseases or those not interested in genetic testing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better identification of genetic risks for diseases, enabling more personalized and effective healthcare strategies for patients.
How similar studies have performed: Previous research has shown promising results in utilizing advanced sequencing technologies to detect genetic variations, indicating that this approach has the potential for significant breakthroughs.
Where this research is happening
Nashville, UNITED STATES
- Vanderbilt University — Nashville, United States (Active)
Researchers
- Principal investigator: Zhou, Xin — Vanderbilt University
- Study coordinator: Zhou, Xin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.